Financhill
Back

Morphic Holding Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
62

MORF
Morphic Holding

Last Price:
28.01
Seasonality Move:
28.92%
Sell
11

NBY
NovaBay Pharmaceuticals

Last Price:
0.08
Seasonality Move:
-9.04%
Buy
62
Morphic Holding (MORF) is a Buy

Is Morphic Holding a Buy, Sell or Hold?

  • The current Morphic Holding [MORF] share price is $27.98. The Score for MORF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • MORF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MORF Stock Price Chart

What is Morphic Holding's stock price today?

  • The Morphic Holding share price today is $27.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MORF is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

MORF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.74 Sell
Relative Strength Index (14 RSI): 34.81 Sell
Chaikin Money Flow: 213333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.05 - 33.85) Sell
Bollinger Bands (100): (27.12 - 35.82) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 28.33 Sell
Chaikin Money Flow: 212946 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.09 - 0.13) Sell
Bollinger Bands (100): (0.11 - 0.23) Sell

MORF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.72 Sell
20-day SMA: 30.75 Sell
50-day SMA: 34.26 Sell
200-day SMA: 35.92 Sell
8-day EMA: 28.68 Sell
20-day EMA: 30.45 Sell
50-day EMA: 32.06 Sell
200-day EMA: 34.48 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.09 Sell
20-day SMA: 0.1 Sell
50-day SMA: 0.13 Sell
200-day SMA: 0.35 Sell
8-day EMA: 0.09 Sell
20-day EMA: 0.1 Sell
50-day EMA: 0.13 Sell
200-day EMA: 0.59 Sell

Morphic Holding Earnings Growth & MORF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.44 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.

Morphic Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):